(P-1484) How do recent population-level RSVpreF vaccine impact results from the United Kingdom relate to previously reported vaccine effectiveness results?

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

QL

Qing Liu, M.S.

Pfizer Inc.
Collegeville, Pennsylvania, United States
CH

Carmen Hockey, MBChB MSc

Dr
Pfizer
London, England, United Kingdom
AV

Andrew Vyse, Ph.D.

Pfizer UK
Tadworth, England, United Kingdom
GE

Gillian Ellsbury, MD

Pfizer ltd
London, England, United Kingdom
LJ

Luis Jodar, PhD

Chief Scientific Officer
Pfizer Vaccines
Collegeville, Pennsylvania, United States
Elizabeth Begier, MD, M.P.H.

Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
Pfizer Vaccines
Dublin, Dublin, Ireland